Taking Diabetes to Heart--deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2013 Nov 27

PMID 24275630

Citations 67

Authors

Marina Bayeva

Konrad Teodor Sawicki

Hossein Ardehali

Affiliations

Soon will be listed here.

Citing Articles

Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice.

Lu Q, Sun H, Zhou K, Su J, Meng X, Chen G J Cachexia Sarcopenia Muscle. 2025; 16(2):e13761.

PMID: 40052435 PMC: 11886612. DOI: 10.1002/jcsm.13761.

Triglyceride glucose index: a significant prognostic marker of heart failure in patients with chronic kidney disease.

Liu S, Chen X, Guo Q, Dou J, Huang J, Jia L Ren Fail. 2024; 46(2):2432547.

PMID: 39604204 PMC: 11610345. DOI: 10.1080/0886022X.2024.2432547.

Beta-adrenergic agonism protects mitochondrial metabolism in the pancreatectomised rat heart.

Lindsay R, Thisted L, Zois N, Thrane S, West J, Fosgerau K Sci Rep. 2024; 14(1):19383.

PMID: 39169098 PMC: 11339431. DOI: 10.1038/s41598-024-70335-4.

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy.

Zeng Y, Li Y, Jiang W, Hou N Front Cardiovasc Med. 2024; 11:1375400.

PMID: 38596692 PMC: 11003275. DOI: 10.3389/fcvm.2024.1375400.

Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.

Heather L, Gopal K, Srnic N, Ussher J Diabetes. 2024; 73(5):659-670.

PMID: 38387045 PMC: 11043056. DOI: 10.2337/dbi23-0019.

References

Ligeti L, Szenczi O, Prestia C, Szabo C, Horvath K, Marcsek Z . Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy. Int J Mol Med. 2006; 17(6):1035-43. View

Woldegiorgis G, Yousufzai S, Shrago E . Studies on the interaction of palmitoyl coenzyme A with the adenine nucleotide translocase. J Biol Chem. 1982; 257(24):14783-7. View

Reaven G, Chang H, Hoffman B . Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes. 1988; 37(1):28-32. DOI: 10.2337/diab.37.1.28. View

Finck B, Lehman J, Leone T, Welch M, Bennett M, Kovacs A . The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109(1):121-30. PMC: 150824. DOI: 10.1172/JCI14080. View

Oancea E, Teruel M, Quest A, Meyer T . Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. J Cell Biol. 1998; 140(3):485-98. PMC: 2140171. DOI: 10.1083/jcb.140.3.485. View

Memon R, Tecott L, Nonogaki K, Beigneux A, MOSER A, Grunfeld C . Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in.... Endocrinology. 2000; 141(11):4021-31. DOI: 10.1210/endo.141.11.7771. View

Park T, Hu Y, Noh H, Drosatos K, Okajima K, Buchanan J . Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res. 2008; 49(10):2101-12. PMC: 2533410. DOI: 10.1194/jlr.M800147-JLR200. View

Kuang M, Febbraio M, Wagg C, Lopaschuk G, Dyck J . Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation. 2004; 109(12):1550-7. DOI: 10.1161/01.CIR.0000121730.41801.12. View

Coort S, Hasselbaink D, Koonen D, Willems J, Coumans W, Chabowski A . Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes. 2004; 53(7):1655-63. DOI: 10.2337/diabetes.53.7.1655. View

10.

Bersin R, Stacpoole P . Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J. 1997; 134(5 Pt 1):841-55. DOI: 10.1016/s0002-8703(97)80007-5. View

11.

Wold L, Ceylan-Isik A, Ren J . Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin. 2005; 26(8):908-17. DOI: 10.1111/j.1745-7254.2005.00146.x. View

12.

Kannel W, Hjortland M, CASTELLI W . Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974; 34(1):29-34. DOI: 10.1016/0002-9149(74)90089-7. View

13.

Zhang L, Ussher J, Oka T, Cadete V, Wagg C, Lopaschuk G . Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovasc Res. 2010; 89(1):148-56. DOI: 10.1093/cvr/cvq266. View

14.

Severson D . Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol. 2004; 82(10):813-23. DOI: 10.1139/y04-065. View

15.

Lopaschuk G, Belke D, Gamble J, Itoi T, Schonekess B . Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1994; 1213(3):263-76. DOI: 10.1016/0005-2760(94)00082-4. View

16.

Xia P, Inoguchi T, Kern T, ENGERMAN R, Oates P, King G . Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994; 43(9):1122-9. DOI: 10.2337/diab.43.9.1122. View

17.

Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H . Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J. 1996; 17(9):1337-44. DOI: 10.1093/oxfordjournals.eurheartj.a015067. View

18.

Wu P, Sato J, Zhao Y, Jaskiewicz J, Popov K, Harris R . Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J. 1998; 329 ( Pt 1):197-201. PMC: 1219032. DOI: 10.1042/bj3290197. View

19.

Shehadeh A, Regan T . Cardiac consequences of diabetes mellitus. Clin Cardiol. 1995; 18(6):301-5. DOI: 10.1002/clc.4960180604. View

20.

Halbirk M, Norrelund H, Moller N, Schmitz O, Gotzsche L, Nielsen R . Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol Heart Circ Physiol. 2010; 299(4):H1220-5. DOI: 10.1152/ajpheart.00475.2010. View